Tesamorelin, CJC-1295 (no DAC), Ipamorelin 12mg (Blend)– Research Overview

This peptide blend combines three well-studied growth hormone–releasing pathway modulators: Tesamorelin, CJC-1295 (No DAC), and Ipamorelin. Each compound interacts with distinct but complementary receptor systems within experimental endocrine models, allowing researchers to explore multi-pathway signaling interactions under controlled laboratory conditions.

Tesamorelin and CJC-1295 (No DAC) function as analogs of growth hormone–releasing hormone (GHRH), while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist. The combination is used in research environments to evaluate receptor synergy, pulsatile hormone modeling, and downstream intracellular signaling cascades.

This 12mg blend is supplied in lyophilized form to preserve structural integrity and support standardized laboratory handling.

Component Overview

Tesamorelin

A stabilized GHRH analog engineered for enhanced resistance to enzymatic degradation. Used in laboratory research to examine GHRH receptor activation and endocrine axis regulation.

CJC-1295 (No DAC)

A modified GHRH analog without Drug Affinity Complex (DAC) attachment. The absence of DAC results in shorter activity duration in experimental systems, allowing researchers to study pulsatile secretion models and acute receptor activation patterns.

Ipamorelin

A selective growth hormone secretagogue receptor (GHS-R1a) agonist. Frequently utilized in research settings to study ghrelin receptor–mediated signaling pathways and calcium-dependent intracellular responses.

Together, these compounds provide a framework for examining dual receptor activation models involving both GHRH and ghrelin receptor systems.

Mechanism of Action (Research Context)

In laboratory studies:

• Tesamorelin and CJC-1295 bind to GHRH receptors located on anterior pituitary somatotroph cells.

• Ipamorelin selectively activates the GHS-R1a receptor.

Activation of these receptors may initiate intracellular cascades such as:

• Adenylate cyclase stimulation

• Increased cyclic AMP (cAMP) production

• Protein kinase A activation

• Calcium ion mobilization

• Downstream transcription pathway modulation

The combined activation of these pathways is studied to evaluate pulsatile growth hormone signaling models and endocrine feedback loop interactions.

Research Applications

This peptide blend is commonly referenced in laboratory research involving:

1. Dual receptor signaling pathway modeling

2. Growth hormone pulsatility studies

3. IGF-1 axis investigations

4. Receptor synergy evaluation

5. Intracellular second messenger analysis

6. Comparative studies of GHRH analogs with and without DAC

Researchers use this combination to explore interactions between GHRH-mediated and ghrelin-mediated signaling systems in controlled experimental settings.

Molecular Stability & Format

The blend is supplied as a lyophilized white powder to maintain peptide integrity during storage and transport. Lyophilization enhances stability by removing moisture and supporting long-term preservation under appropriate refrigeration.

For laboratory handling:

• Store under recommended refrigerated conditions

• Avoid repeated freeze–thaw cycles

• Reconstitute using sterile laboratory-grade solvent

• Follow institutional peptide handling protocols

Product Specifications

• Compounds: Tesamorelin, CJC-1295 (No DAC), Ipamorelin

• Total Strength: 12mg combined peptide content

• Form: Lyophilized sterile powder

• Appearance: White to off-white solid

• Storage: Refrigerated conditions recommended

• Use: Laboratory research only

Quality & Analytical Standards

Each batch undergoes analytical verification to confirm peptide identity and purity using validated laboratory methodologies. Lot numbers are assigned to support traceability and documentation within research environments.

Quality control procedures are implemented to maintain consistency across production batches.

Compliance Notice

Tesamorelin, CJC-1295 (No DAC), and Ipamorelin 12mg blend is intended strictly for laboratory research use.

It is not approved for human consumption, therapeutic application, or clinical use.

This product is sold exclusively for in vitro research, analytical testing, and scientific investigation by qualified professionals.